NCT00236665View on ClinicalTrials.gov

A Study of Efficacy and Safety of Topiramate in the Treatment of Obese Patients With Mild to Moderate Essential Hypertension

PHASE3CompletedINTERVENTIONAL
Enrollment

531

Participants

Timeline

Start Date

March 31, 2001

Study Completion Date

June 30, 2002

Conditions
ObesityHypertension
Interventions
DRUG

topiramate

All Listed Sponsors
lead

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

INDUSTRY

NCT00236665 - A Study of Efficacy and Safety of Topiramate in the Treatment of Obese Patients With Mild to Moderate Essential Hypertension | Biotech Hunter | Biotech Hunter